Home » Topics » Regulatory

Regulatory
RSS

Kalydeco approved in U.S. for cystic fibrosis in patients aged 12 to < 24 months

Aug. 16, 2018

FDA approves The Population Council's 1-year contraceptive Annovera

Aug. 13, 2018

Alnylam's RNAi therapeutic Onpattro for polyneuropathy of hATTR amyloidosis receives first approval

Aug. 13, 2018

FDA approves Arakoda for prevention of malaria

Aug. 10, 2018

Petrovax Pharm's 4-valeant influenza vaccine --Grippol Quadrivalent-- approved in Russia

Aug. 10, 2018

FDA approves Poteligeo for two subtypes of cutaneous T-cell lymphoma

Aug. 9, 2018

FDA expands approval of Orkambi to children 2 to 5 years of age

Aug. 8, 2018

European Commission approves Pfizer trastuzumab biosimilar Trazimera

Aug. 1, 2018

FDA approves Azedra for pheochromocytoma or paraganglioma

July 31, 2018

FDA approves single-dose Krintafel for radical cure of P. vivax malaria

July 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...